Insmed (INSM) Insider Trading & Ownership $72.29 -0.13 (-0.18%) (As of 12:45 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Insmed (NASDAQ:INSM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.60%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$23.68 M Get INSM Insider Trade Alerts Want to know when executives and insiders are buying or selling Insmed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address INSM Insider Buying and Selling by Quarter Ad Porter & CompanyElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. Insmed Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/16/2024Martina M.D. FlammerInsiderSell13,436$74.92$1,006,625.12 9/13/2024Michael Alexander SmithInsiderSell27,871$74.35$2,072,208.85 9/10/2024Orlov S Nicole SchaefferInsiderSell37,575$71.50$2,686,612.50 6/21/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$67.99$1,001 - $15,0005/30/2024Martina M.D. FlammerInsiderSell21,195$55.00$1,165,725.00 5/29/2024Sara BonsteinCFOSell220,564$50.00$11,028,200.00 5/28/2024John Drayton WiseInsiderSell7,852$49.79$390,951.08 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/28/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$48.06$1,001 - $15,0005/14/2024John Drayton WiseInsiderSell5,088$25.47$129,591.36 5/14/2024Roger AdsettCOOSell7,857$25.50$200,353.50 5/14/2024Sara BonsteinCFOSell11,088$25.32$280,748.16 5/14/2024William LewisCEOSell22,198$25.52$566,492.96 1/12/2024Martina M.D. FlammerInsiderSell4,667$28.63$133,616.21 1/12/2024Roger AdsettCOOSell5,251$28.63$150,336.13 1/9/2024John Drayton WiseInsiderSell1,861$28.78$53,559.58 1/9/2024Michael Alexander SmithVPSell2,373$28.76$68,247.48 1/9/2024Roger AdsettCOOSell3,837$29.25$112,232.25 1/9/2024Sara BonsteinCFOSell4,497$29.18$131,222.46 1/8/2024William LewisCEOSell45,120$29.45$1,328,784.00 1/5/2024John Drayton WiseInsiderSell1,167$29.32$34,216.44 1/5/2024Michael Alexander SmithVPSell627$29.30$18,371.10 1/5/2024Roger AdsettCOOSell3,042$29.21$88,856.82 1/5/2024William LewisCEOSell6,979$29.26$204,205.54 1/3/2024John Drayton WiseInsiderSell20,071$29.19$585,872.49 12/22/2023Martina M.D. FlammerInsiderSell28,310$30.00$849,300.00 12/22/2023Sara BonsteinCFOSell13,199$30.00$395,970.00 (Data available from 1/1/2013 forward) INSM Insider Trading Activity - Frequently Asked Questions Who is on Insmed's Insider Roster? The list of insiders at Insmed includes John Drayton Wise, Martina M.D. Flammer, Melvin Md Sharoky, Michael Alexander Smith, Orlov S Nicole Schaeffer, Roger Adsett, Sara Bonstein, and William Lewis. Learn more on insiders at INSM. What percentage of Insmed stock is owned by insiders? 4.60% of Insmed stock is owned by insiders. Learn more on INSM's insider holdings. Which Insmed insiders have been selling company stock? The following insiders have sold INSM shares in the last 24 months: John Drayton Wise ($1,231,080.19), Martina M.D. Flammer ($3,326,152.69), Michael Alexander Smith ($2,220,878.51), Orlov S Nicole Schaeffer ($2,686,612.50), Roger Adsett ($842,870.68), Sara Bonstein ($11,887,909.46), and William Lewis ($5,061,092.90). How much insider selling is happening at Insmed? Insiders have sold a total of 673,906 Insmed shares in the last 24 months for a total of $27,256,596.93 sold. Which members of congress are trading Insmed? Josh Gottheimer (D-NJ) has sold shares of Insmed in the last year totaling $16,000. Insmed Key ExecutivesMr. William H. Lewis J.D. (Age 50)Pres, CEO & Chairman Mr. Paolo Tombesi (Age 55)Chief Financial Officer Ms. Christine A. Pellizzari J.D. (Age 51)Chief Legal Officer & Corp. Sec. Mr. Roger Adsett (Age 50)Chief Commercial Officer Dr. Paul D. Streck (Age 55)Advisor More Insider Trading Tools from MarketBeat Related Companies Takeda Pharmaceutical Insider Buying Alnylam Pharmaceuticals Insider Buying BeiGene Insider Buying Teva Pharmaceutical Industries Insider Buying United Therapeutics Insider Buying Viatris Insider Buying Royalty Pharma Insider Buying Genmab A/S Insider Buying Summit Therapeutics Insider Buying BioMarin Pharmaceutical Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024?Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in Buybacks This page (NASDAQ:INSM) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insmed Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Insmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
